Alpha Wave Global’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-39,219
Closed -$2.99M 35
2023
Q1
$2.99M Buy
+39,219
New +$3.25M 1.1% 24

Other funds holding XBI

Alpha Wave Global's XBI Position: Q2 2023 in Review

Alpha Wave Global sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 39,219 shares — an estimated $2.99M sold.

Alpha Wave Global first reported a position in XBI in Q1 2023 and held it in 1 quarter. The position peaked at $2.99M in Q1 2023. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

  • Alpha Wave Global reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
  • Alpha Wave Global sold 39,219 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $2.99M.
  • Alpha Wave Global first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 1 quarter.
  • Alpha Wave Global's State Street SPDR S&P Biotech ETF position peaked at $2.99M in Q1 2023.
  • 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Alpha Wave Global's 13F filing for Q2 2023, filed 14 Aug 2023.